Previous studies have shown that AXL and CD209 are ZIKV receptors, and in skin cells, AXL is much more efficient than CD209, TYRO3, and TIM in promoting ZIKV infection (24, 26, 52, –, 54). This evidence concerns the gene TYRO3 and Zika virus infectious disease.